Bulls vs Bears
Click to unlock major analysts' bullish and bearish positions by joining Benzinga Edge.
$15.63
-0.38-2.37%
At close: -
$15.63
0.000.00%
After Hours: Jun 13, 4:00 PM EDT
Comments
Loading...
Dentsply Sirona Analyst Ratings and Price Targets | NASDAQ:XRAY | Benzinga
Dentsply Sirona Inc has a consensus price target of $21.82 based on the ratings of 15 analysts. The high is $30 issued by Goldman Sachs on May 6, 2024. The low is $16 issued by Piper Sandler on April 30, 2025. The 3 most-recent analyst ratings were released by Barrington Research, UBS, and Piper Sandler on May 12, 2025, May 9, 2025, and April 30, 2025, respectively. With an average price target of $20.67 between Barrington Research, UBS, and Piper Sandler, there's an implied 32.22% upside for Dentsply Sirona Inc from these most-recent analyst ratings.
Analyst Firms Making Recommendations1
Barrington Research
UBS
Piper Sandler
Mizuho
Wells Fargo
1calculated from analyst ratings
Analyst Ratings for Dentsply Sirona
| Buy Now | Get Alert | |||||||
|---|---|---|---|---|---|---|---|---|
| 05/12/2025 | Buy Now | 34.36% | Barrington Research | Michael Petusky50% | $20 → $21 | Maintains | Outperform | Get Alert |
| 05/09/2025 | Buy Now | 59.95% | UBS | Kevin Caliendo71% | $27 → $25 | Maintains | Buy | Get Alert |
| 04/30/2025 | Buy Now | 2.37% | Piper Sandler | Jason Bednar53% | $20 → $16 | Maintains | Neutral | Get Alert |
| 03/13/2025 | Buy Now | 15.16% | Mizuho | Steven Valiquette63% | $21 → $18 | Maintains | Neutral | Get Alert |
| 03/13/2025 | Buy Now | — | Needham | David Saxon56% | — | Downgrade | Buy → Hold | Get Alert |
| 02/28/2025 | Buy Now | 21.56% | Wells Fargo | Vik Chopra43% | $20 → $19 | Maintains | Equal-Weight | Get Alert |
| 02/28/2025 | Buy Now | 27.96% | Barrington Research | Michael Petusky50% | $24 → $20 | Maintains | Outperform | Get Alert |
| 02/28/2025 | Buy Now | 27.96% | Baird | Jeffrey Johnson38% | $22 → $20 | Maintains | Neutral | Get Alert |
| 02/28/2025 | Buy Now | 47.15% | Needham | David Saxon56% | $25 → $23 | Maintains | Buy | Get Alert |
| 02/14/2025 | Buy Now | 27.96% | Wells Fargo | Vik Chopra43% | → $20 | Initiates | → Equal-Weight | Get Alert |
| 02/11/2025 | Buy Now | 59.95% | Needham | David Saxon56% | $25 → $25 | Reiterates | Buy → Buy | Get Alert |
| 01/30/2025 | Buy Now | 59.95% | Needham | David Saxon56% | $23 → $25 | Maintains | Buy | Get Alert |
| 01/23/2025 | Buy Now | 27.96% | Jefferies | Glen Santangelo50% | $30 → $20 | Downgrade | Buy → Hold | Get Alert |
| 01/07/2025 | Buy Now | 27.96% | Evercore ISI Group | Elizabeth Anderson47% | → $20 | Downgrade | Outperform → In-Line | Get Alert |
| 12/17/2024 | Buy Now | 47.15% | Morgan Stanley | Erin Wright75% | $30 → $23 | Maintains | Overweight | Get Alert |
| 12/04/2024 | Buy Now | 34.36% | Mizuho | Steven Valiquette63% | → $21 | Initiates | → Neutral | Get Alert |
| 12/03/2024 | Buy Now | 72.74% | UBS | Kevin Caliendo71% | $35 → $27 | Maintains | Buy | Get Alert |
| 11/08/2024 | Buy Now | 53.55% | Barrington Research | Michael Petusky50% | $36 → $24 | Maintains | Outperform | Get Alert |
| 11/08/2024 | Buy Now | 53.55% | Baird | Jeffrey Johnson38% | $31 → $24 | Maintains | Neutral | Get Alert |
| 11/07/2024 | Buy Now | — | Leerink Partners | Michael Cherny77% | — | Downgrade | Outperform → Market Perform | Get Alert |
| 10/28/2024 | Buy Now | 85.54% | Needham | David Saxon56% | $34 → $29 | Maintains | Buy | Get Alert |
| 10/08/2024 | Buy Now | 72.74% | Evercore ISI Group | Elizabeth Anderson47% | $29 → $27 | Maintains | Outperform | Get Alert |
| 09/20/2024 | Buy Now | 130.33% | Barrington Research | Michael Petusky50% | $36 → $36 | Maintains | Outperform | Get Alert |
| 08/20/2024 | Buy Now | 117.53% | Needham | David Saxon56% | $34 → $34 | Reiterates | Buy → Buy | Get Alert |
| 07/31/2024 | Buy Now | 117.53% | Needham | David Saxon56% | $36 → $34 | Maintains | Buy | Get Alert |
| 07/22/2024 | Buy Now | 98.34% | Baird | Jeffrey Johnson38% | $33 → $31 | Maintains | Neutral | Get Alert |
| 07/18/2024 | Buy Now | 79.14% | Stifel | Jonathan Block72% | $30 → $28 | Maintains | Hold | Get Alert |
| 07/09/2024 | Buy Now | 72.74% | Evercore ISI Group | Elizabeth Anderson47% | $28 → $27 | Maintains | Outperform | Get Alert |
| 07/08/2024 | Buy Now | 143.12% | Barrington Research | Michael Petusky50% | $38 → $38 | Maintains | Outperform | Get Alert |
| 06/25/2024 | Buy Now | 79.14% | Evercore ISI Group | Elizabeth Anderson47% | $35 → $28 | Maintains | Outperform | Get Alert |
| 05/06/2024 | Buy Now | 91.94% | Goldman Sachs | Nathan Rich42% | $34 → $30 | Maintains | Neutral | Get Alert |
| 05/03/2024 | Buy Now | 123.93% | Evercore ISI Group | Elizabeth Anderson47% | $40 → $35 | Maintains | Outperform | Get Alert |
| 05/03/2024 | Buy Now | 143.12% | Barrington Research | Michael Petusky50% | $41 → $38 | Maintains | Outperform | Get Alert |
| 05/03/2024 | Buy Now | 104.73% | Piper Sandler | Jason Bednar53% | $35 → $32 | Reiterates | Neutral → Neutral | Get Alert |
| 05/03/2024 | Buy Now | 111.13% | Baird | Jeffrey Johnson38% | $35 → $33 | Maintains | Neutral | Get Alert |
| 05/03/2024 | Buy Now | 130.33% | Needham | David Saxon56% | $42 → $36 | Maintains | Buy | Get Alert |
| 04/18/2024 | Buy Now | 162.32% | Barrington Research | Michael Petusky50% | $41 → $41 | Maintains | Outperform | Get Alert |
| 03/01/2024 | Buy Now | 162.32% | Barrington Research | Michael Petusky50% | → $41 | Reiterates | Outperform → Outperform | Get Alert |
| 02/29/2024 | Buy Now | 168.71% | Needham | David Saxon56% | $42 → $42 | Reiterates | Buy → Buy | Get Alert |
| 02/26/2024 | Buy Now | 168.71% | Leerink Partners | Michael Cherny77% | → $42 | Initiates | → Outperform | Get Alert |
| 01/12/2024 | Buy Now | 123.93% | Piper Sandler | Jason Bednar53% | $31 → $35 | Maintains | Neutral | Get Alert |
| 01/09/2024 | Buy Now | 168.71% | Needham | David Saxon56% | $35 → $42 | Maintains | Buy | Get Alert |
| 11/16/2023 | Buy Now | 123.93% | Needham | David Saxon56% | → $35 | Initiates | → Buy | Get Alert |
| 11/13/2023 | Buy Now | 104.73% | Stifel | Jonathan Block72% | $35 → $32 | Maintains | Hold | Get Alert |
| 11/10/2023 | Buy Now | — | William Blair | Brandon Vazquez65% | — | Upgrade | Market Perform → Outperform | Get Alert |
| 11/07/2023 | Buy Now | 130.33% | Goldman Sachs | Nathan Rich42% | $42 → $36 | Maintains | Neutral | Get Alert |
| 11/03/2023 | Buy Now | 162.32% | Barrington Research | Michael Petusky50% | $51 → $41 | Maintains | Outperform | Get Alert |
| 11/03/2023 | Buy Now | 149.52% | Morgan Stanley | Erin Wright75% | $43 → $39 | Maintains | Overweight | Get Alert |
| 11/01/2023 | Buy Now | 123.93% | Stifel | Jonathan Block72% | $41 → $35 | Maintains | Hold | Get Alert |
| 10/20/2023 | Buy Now | 175.11% | Morgan Stanley | Erin Wright75% | $47 → $43 | Maintains | Overweight | Get Alert |
| 09/22/2023 | Buy Now | 149.52% | Piper Sandler | Jason Bednar53% | $42 → $39 | Maintains | Neutral | Get Alert |
| 08/04/2023 | Buy Now | 226.3% | Barrington Research | Michael Petusky50% | → $51 | Reiterates | → Outperform | Get Alert |
| 05/04/2023 | Buy Now | 226.3% | Barrington Research | Michael Petusky50% | $43 → $51 | Reiterates | → Outperform | Get Alert |
| 05/04/2023 | Buy Now | 162.32% | Stifel | Jonathan Block72% | $37 → $41 | Maintains | Hold | Get Alert |
| 05/04/2023 | Buy Now | 200.7% | Morgan Stanley | Erin Wright75% | $45 → $47 | Maintains | Overweight | Get Alert |
| 05/04/2023 | Buy Now | 194.31% | Baird | Jeffrey Johnson38% | $36 → $46 | Maintains | Neutral | Get Alert |
| 04/19/2023 | Buy Now | 187.91% | Morgan Stanley | Erin Wright75% | $39 → $45 | Maintains | Overweight | Get Alert |
| 03/02/2023 | Buy Now | 149.52% | Goldman Sachs | Nathan Rich42% | $34 → $39 | Maintains | Neutral | Get Alert |
| 03/01/2023 | Buy Now | 149.52% | Goldman Sachs | Nathan Rich42% | $34 → $39 | Maintains | Neutral | Get Alert |
| 02/06/2023 | Buy Now | 123.93% | Piper Sandler | Jason Bednar53% | $29 → $35 | Maintains | Neutral | Get Alert |
| 01/12/2023 | Buy Now | — | William Blair | Brandon Vazquez65% | — | Upgrade | Underperform → Market Perform | Get Alert |
| 11/16/2022 | Buy Now | 117.53% | Goldman Sachs | Nathan Rich42% | $41 → $34 | Maintains | Neutral | Get Alert |
| 11/15/2022 | Buy Now | 149.52% | Morgan Stanley | Erin Wright75% | $42 → $39 | Maintains | Overweight | Get Alert |
| 10/13/2022 | Buy Now | 168.71% | Morgan Stanley | Erin Wright75% | $44 → $42 | Maintains | Overweight | Get Alert |
| 08/05/2022 | Buy Now | — | William Blair | John Kreger50% | — | Downgrade | Market Perform → Underperform | Get Alert |
| 07/21/2022 | Buy Now | 162.32% | Goldman Sachs | Nathan Rich42% | $42 → $41 | Maintains | Neutral | Get Alert |
| 07/20/2022 | Buy Now | 181.51% | Morgan Stanley | Erin Wright75% | $48 → $44 | Maintains | Overweight | Get Alert |
FAQ
What is the target price for Dentsply Sirona (XRAY) stock?
The latest price target for Dentsply Sirona (NASDAQ:XRAY) was reported by Barrington Research on May 12, 2025. The analyst firm set a price target for $21.00 expecting XRAY to rise to within 12 months (a possible 34.36% upside). 30 analyst firms have reported ratings in the last year.
What is the most recent analyst rating for Dentsply Sirona (XRAY)?
The latest analyst rating for Dentsply Sirona (NASDAQ:XRAY) was provided by Barrington Research, and Dentsply Sirona maintained their outperform rating.
When was the last upgrade for Dentsply Sirona (XRAY)?
The last upgrade for Dentsply Sirona Inc happened on November 10, 2023 when William Blair raised their price target to N/A. William Blair previously had a market perform for Dentsply Sirona Inc.
When was the last downgrade for Dentsply Sirona (XRAY)?
The last downgrade for Dentsply Sirona Inc happened on March 13, 2025 when Needham changed their price target from N/A to N/A for Dentsply Sirona Inc.
When is the next analyst rating going to be posted or updated for Dentsply Sirona (XRAY)?
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Dentsply Sirona, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Dentsply Sirona was filed on May 12, 2025 so you should expect the next rating to be made available sometime around May 12, 2026.
Is the Analyst Rating Dentsply Sirona (XRAY) correct?
While ratings are subjective and will change, the latest Dentsply Sirona (XRAY) rating was a maintained with a price target of $20.00 to $21.00. The current price Dentsply Sirona (XRAY) is trading at is $15.63, which is out of the analyst’s predicted range.
Browse analyst ratings and price targets on all stocks.
